Margetuximab in HER2-positive metastatic breast cancer
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - May 12, 2023 Category: Cancer & Oncology Authors: William J Gradishar Ruth O'Regan Mothaffar F Rimawi Jeffrey L Nordstrom Minori K Rosales Hope S Rugo Source Type: research
Current state and future perspectives for palliative care in Latin America with a special focus on Peru
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - May 12, 2023 Category: Cancer & Oncology Authors: Rolig Abad Aliaga Ch ávez Reina Isabel Bustamante Coronado Mirna Liliana Chumbes Sipan Oswaldo Abelardo Grados S ánchez Ricardo R ómulo Paredes Pascual Jos é Luis Salinas Paz Nestor Ra úl Juárez Herrera Omar Antonio S ímon Escudero H éctor Ysmael Source Type: research
High tumor burden in patients with non-small-cell lung cancer: a Delphi survey among Spanish oncologists
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - May 12, 2023 Category: Cancer & Oncology Authors: Mar ía Sereno Luis Cabez ón-Gutiérrez Oliver Higuera Xabier Mielgo-Rubio Raquel Cervera-Calero Source Type: research
Comparison of advanced ovarian cancer patients treated with or without bevacizumab in the US Community Oncology Clinics
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - May 12, 2023 Category: Cancer & Oncology Authors: Richard W DeClue Elizabeth A Szamreta Santosh Gautam Maxine D Fisher Matthew J Monberg Source Type: research
Defining ruxolitinib failure and transition to next-line therapy for patients with myelofibrosis: a modified Delphi panel consensus study
Future Oncology, Ahead of Print. (Source: Future Oncology)
Source: Future Oncology - May 10, 2023 Category: Cancer & Oncology Authors: John Mascarenhas Hiep Nguyen Ashley Saunders Louisa Oliver Hannah Tomkinson Richard Perry Ali McBride Source Type: research
